
    
      Phase II clinical trial for the patients with newly diagnosed. TCD (thalidomide,
      cyclophosphamide and dexamethasone) will be applied for the patients as an induction
      chemotherapy, followed by high dose chemotherpy and autologous stem cell transplantation.
      Afterthen, they will receive TD (thalidomide and dexamethasone) maintenance therapy for one
      year.
    
  